Nutra Pharma Corp (NPHC) Receivables - Other (2010 - 2026)

Nutra Pharma has disclosed Receivables - Other across 12 years of filings, most recently posting $307732.0 for Q2 2026.

• In Q2 2026, Receivables - Other rose 138.73% year-over-year to $307732.0; the TTM figure through Jun 2026 stood at $307732.0 (up 138.73% YoY), while the FY2025 annual figure was $293847.0, up 328.97% from the prior year.
• Receivables - Other came in at $307732.0 for Q2 2026 at Nutra Pharma, up from $133906.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $307732.0 in Q2 2026 to a low of -$5000.0 in Q3 2024.
• Average Receivables - Other over 5 years is $64311.4, with a median of $29453.0 recorded in 2024.
• Year-over-year, Receivables - Other tumbled 114.2% in 2024 and soared 3044.0% in 2025.
• Over 5 years, Receivables - Other stood at $3000.0 in 2022, then surged by 33.33% to $4000.0 in 2023, then jumped by 622.65% to $28906.0 in 2024, then climbed by 3.78% to $30000.0 in 2025, then jumped by 925.77% to $307732.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Other figures were $307732.0 in Q2 2026, $133906.0 in Q1 2026, and $30000.0 in Q4 2025.